Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Joint Event on International Conference on CANCER THERAPY & International Conference on VACCINES & VACCINATION

July 23-24, 2018 | Osaka, Japan

Posters & Accepted Abstracts

J Clin Exp Oncol
Manassantin B, a neolignan isolated from the roots of Saururus Chinensis inhibits VEGF-A-induced lymphangiogenesis and lymph node metastasis both in vitro and in vivo

Jeon Hwang-Bo, Mun Gyeong Bae and In Sik Chung

PDF  |   HTML   
J Clin Exp Oncol
6,8-Diprenylgenistein, an isoflavonoid isolated from Cudrania tricuspidata fruit inhibits VEGF-Ainduced lymphangiogenesis and metastasis in an oral cancer sentinel lymph node animal model

Mun Gyeong Bae, Jeon Hwang-Bo and In Sik Chung

PDF  |   HTML   
J Clin Exp Oncol
Genetic platform for local and remote recurrence in early breast cancer Edgardo Rebagliati Martins Hospital 2011-2013

Ana Cecilia Fernandez Butron, Yenny Geronimo and Manuel Fernandez Lopez

PDF  |   HTML   
J Clin Exp Oncol
Cancerous immunoglobulins and potential clinical applications

Gregory Lee, Song-Nan Chow, Chin-Hsiang Chien

PDF  |   HTML   
J Clin Exp Oncol
T-cell therapeutic vaccine for autoimmune components of viral infections

Henri ATLAN

PDF  |   HTML   
J Clin Exp Oncol
Novel strategy to cure cancer

Adnan Yousif Rojeab

PDF  |   HTML   
J Clin Exp Oncol
Development of recombinant vaccine by individually cloning of HIV1 C gag, env and polRT genes using Semliki forest virus vector

A H Bandivdekar

PDF  |   HTML   
J Clin Exp Oncol
Cancer cured by bio electrons laser acupuncture

Nick Kostovic

PDF  |   HTML   
J Clin Exp Oncol
Prognostic importance of Thrombopoietin after radiotherapy: a prospective study

Amar Ranjan, Pranay Tanwar and Julieana Durai

PDF  |   HTML   
J Clin Exp Oncol
LCZ 696 is superior to Valsartan in the prevention of cardiotoxity induced by trastuzumab, pertuzumab and Trastuzumab-DM1 monoclonal antibodies

N. Maurea, R. Paciello, G. Piscopo, G. Sorrentino, C. Maurea1, C. Coppola and C. De Lorenzo

PDF  |   HTML   
J Clin Exp Oncol
Redox signaling in cell response to radiotherapy

Yong Xu

PDF  |   HTML   
J Clin Exp Oncol
Toward the development of universal influenza vaccines and vaccination regimens

Chang-Won (Charles) Lee, Renukaradhya Gourapura and John M Ngunjiri

PDF  |   HTML   
J Clin Exp Oncol
The challenge of eradicating Meningococcus outbreaks through vaccines

Ohimain EI

PDF  |   HTML   
J Clin Exp Oncol
Development of 2 unique vaccines with multiple applications

G P Talwar

PDF  |   HTML   
J Clin Exp Oncol
Indirect protection in action: Evidence from childhood influenza vaccination programmes

George Kassianos

PDF  |   HTML   
J Clin Exp Oncol
How does NHS England manage to achieve one of the highest seasonal influenza vaccination rates

George Kassianos

PDF  |   HTML   
J Clin Exp Oncol
Shotgun phage display for the identification of new adhesins from Leptospira interrogans

Lauretti FF, Teixeira AAR, Giordano RJ and Ho PL

PDF  |   HTML   
J Clin Exp Oncol
Nuclear protein profile changes in response to infections of human metapneumovirus vaccine candidates

Xiaoyong Bao  Yuping Ren, Ke Zhang, Yu Chen, Xiaoling Deng and Kangling Zhang

PDF  |   HTML   
J Clin Exp Oncol
Mechanistic and molecular basis of tumour evasion from cytotoxic T cells (CTL) surveillance in pancreatic cancers progress study report

Pawel Suwinski

PDF  |   HTML   
J Clin Exp Oncol
Cancer immunotherapy: Breakthrough or deja vu, all over again?

Stewart Sell

PDF  |   HTML   
J Clin Exp Oncol
Gram positive cell factories: production of disulfide-rich recombinant Plasmodium falciparum malaria vaccine candidates in Lactococcus lactis

Susheel K Singh, Bishwanath Kumar Chourasia, Regis Wendpayangde Tiendrebeogo, Ikhlaq Hussain Kana, Subhash Singhand Michael
Theisen

PDF  |   HTML   

Track Your Manuscript

Media Partners

GET THE APP